We conclude that the AML-associated NPM mutants A and E display significantly higher affinity for CRM1HA than wild type NPM, although the technical problems encountered do not allow us to ascertain if any mutant (A or E) is better recognized by CRM1HA. This evidence concerns the gene NPM1 and acute myeloid leukemia.